Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Oboho IK"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-4 z 4
    Tytuł:
    Association of Higher MERS-CoV Virus Load with Severe Disease and Death, Saudi Arabia, 2014.
    Autorzy:
    Feikin DR
    Alraddadi B
    Qutub M
    Shabouni O
    Curns A
    Oboho IK
    Tomczyk SM
    Wolff B
    Watson JT
    Madani TA
    Pokaż więcej
    Źródło:
    Emerging infectious diseases [Emerg Infect Dis] 2015 Nov; Vol. 21 (11), pp. 2029-35.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
    MeSH Terms:
    Coronavirus/*genetics
    Coronavirus Infections/*mortality
    Adolescent ; Adult ; Aged ; Child ; Coronavirus/immunology ; Coronavirus Infections/epidemiology ; Coronavirus Infections/immunology ; Coronavirus Infections/virology ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Saudi Arabia/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Autorzy:
    Tweya H; The International Union Against Tuberculosis and Lung Disease, Paris, France.; Lighthouse Trust, Lilongwe, Malawi.
    Oboho IK; Division of Global HIV and Tuberculosis (DGHT), Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, United States of America.
    Gugsa ST; Lighthouse Trust, Lilongwe, Malawi.; International Training and Education Center for Health (I-TECH), Lilongwe, Malawi.
    Phiri S; Lighthouse Trust, Lilongwe, Malawi.; Department of Public Health, School of Public Health and Family Medicine, College of Medicine, University of Malawi, Lilongwe, Malawi.; Department of Medicine, School of Medicine, University of North Carolina Chapel Hill, Chapel Hill, NC, United States of America.
    Rambiki E; Bwaila Hospital, Ministry of Health, Lilongwe, Malawi.
    Banda R; Lighthouse Trust, Lilongwe, Malawi.
    Mwafilaso J; Lighthouse Trust, Lilongwe, Malawi.
    Munthali C; Baobab Health Trust, Lilongwe, Malawi.
    Gupta S; Division of Global HIV and Tuberculosis (DGHT), Center for Global Health, Centers for Disease Control and Prevention (CDC), Lilongwe, Malawi.
    Bateganya M; Division of Global HIV and Tuberculosis (DGHT), Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, United States of America.
    Maida A; Division of Global HIV and Tuberculosis (DGHT), Center for Global Health, Centers for Disease Control and Prevention (CDC), Lilongwe, Malawi.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2018 Jan 26; Vol. 13 (1), pp. e0188488. Date of Electronic Publication: 2018 Jan 26 (Print Publication: 2018).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Lost to Follow-Up*
    HIV Infections/*drug therapy
    Adolescent ; Adult ; Aged ; Anti-HIV Agents/therapeutic use ; Cohort Studies ; Female ; Follow-Up Studies ; HIV Infections/complications ; Humans ; Malawi ; Male ; Middle Aged ; Patient Compliance ; Pregnancy ; Pregnancy Complications, Infectious/drug therapy ; Retrospective Studies ; Risk Factors ; Rural Health Services ; Urban Health Services ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Modelling the impact of CD4 testing on mortality from TB and cryptococcal meningitis among patients with advanced HIV disease in nine countries.
    Autorzy:
    Oboho IK; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
    Paulin H; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
    Corcoran C; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
    Hamilton M; Avenir Health, Glastonbury, Connecticut, USA.
    Jordan A; Division of Foodborne, Waterborne and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
    Kirking HL; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
    Agyemang E; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
    Podewils LJ; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Denver Health and Hospital Authority, Denver, Colorado, USA.
    Pretorius C; Avenir Health, Glastonbury, Connecticut, USA.
    Greene G; Division of Foodborne, Waterborne and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
    Chiller T; Division of Foodborne, Waterborne and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
    Desai M; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; U.S. Office of Global AIDS Coordinator and Health Diplomacy, Washington, DC, USA.
    Bhatkoti R; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
    Shiraishi RW; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
    Shah NS; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Emory Rollins School of Public Health, Atlanta, Georgia, USA.
    Pokaż więcej
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2023 Mar; Vol. 26 (3), pp. e26070.
    Typ publikacji:
    Journal Article; Research Support, U.S. Gov't, P.H.S.
    MeSH Terms:
    HIV Infections*/complications
    HIV Infections*/drug therapy
    Meningitis, Cryptococcal*/diagnosis
    Meningitis, Cryptococcal*/drug therapy
    Meningitis, Cryptococcal*/epidemiology
    Opportunistic Infections*
    Tuberculosis*
    Adult ; Humans ; Algorithms ; CD4 Antigens/immunology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-4 z 4

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies